ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 123 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $9,912,393 | -22.6% | 457,654 | +0.4% | 0.02% | -20.8% |
| Q2 2022 | $12,804,360 | +4.0% | 455,684 | +70.8% | 0.02% | +41.2% |
| Q1 2022 | $12,309,753 | +9.8% | 266,786 | +100.0% | 0.02% | -41.4% |
| Q4 2021 | $11,213,000 | +27.7% | 133,392 | +1.2% | 0.03% | +16.0% |
| Q3 2021 | $8,783,000 | -35.0% | 131,801 | -48.1% | 0.02% | +31.6% |
| Q2 2021 | $13,506,000 | +89.8% | 253,890 | +54.8% | 0.02% | -13.6% |
| Q1 2021 | $7,116,000 | -14.9% | 164,012 | +1.9% | 0.02% | -15.4% |
| Q4 2020 | $8,361,000 | +63.9% | 160,970 | +3.1% | 0.03% | +44.4% |
| Q3 2020 | $5,102,000 | -50.2% | 156,087 | -26.8% | 0.02% | -10.0% |
| Q2 2020 | $10,242,000 | – | 213,286 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,664,409 | $177,556,000 | 4.47% |
| Avidity Partners Management LP | 2,493,800 | $166,187,000 | 3.68% |
| Matrix Capital Management Company, LP | 4,349,279 | $289,836,000 | 3.30% |
| Integral Health Asset Management, LLC | 90,000 | $5,998,000 | 1.72% |
| Affinity Asset Advisors, LLC | 77,500 | $5,165,000 | 1.30% |
| Ghost Tree Capital, LLC | 65,000 | $4,332,000 | 1.27% |
| Ikarian Capital, LLC | 200,000 | $13,328,000 | 0.94% |
| HighVista Strategies LLC | 20,596 | $1,373,000 | 0.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 23,855 | $1,590,000 | 0.90% |
| Woodline Partners LP | 507,847 | $33,843,000 | 0.55% |